Everett Jolly interviews Andrew Kucharchuk, CFO for OncBioMune Pharmaceuticals, Inc. (OBMP) and discussing Phase 2 Trials for their new drug that is designed for stage 4 prostate cancer patients.
MILFORD, Pa., (UPTICK Newswire - February 16th, 2016) -- Manzo Pharmaceuticals, Inc. (OTCPink:MNZO), today announced that the human study testing results for its lactose intolerance product, Lacto-Freedom™ are so positive that the…
-Innovus Pharma’s Aggregate Annual Revenues Expected to Triple to Close to $4.0 Million SAN DIEGO, CA: (UPTICK Newswire - February 11, 2016) – Innovus Pharmaceuticals, Inc., (“Innovus Pharma” or the…
James Nathanielsz returns to Uptick Network and talks with Everett Jolly about extending brand awareness for Propanc Health Group Corp. (PPCH) across Europe and the United States. UPTICK Newswire provides paid…
Everett Jolly Interviews James Nathanielsz, CEO of Propanc Health Group Corp. (PPCH) and discuss revolutionary developments in Cancer research and treatment. UPTICK Newswire provides paid IR services for Propanc Health…
Files Third Patent Citing New Treatment Method to Halt Cancer Progression MELBOURNE, Australia, (UPTICK Newswire - Feb. 4, 2016) -- Propanc Health Group Corporation (PPCH) ("Propanc" or "the Company"), an emerging…
ORLANDO, Fla., (UPTICK Newswire - February 03, 2016) - Recently, Innovus Pharmaceuticals, Inc., (OTCQB:INNV) announced that they had expanded distribution for their widening product line by adding 18 new distributors.…
Everett Jolly interviews CEO Bill Hartman from Premier Biomedical Inc. (BIEI) talks about their process for developing new medical advancements and medications. We are pleased to share the following…
Part 1 - Interview with CEO of Immune Pharmaceuticals Dr. Daniel Teper Part 2 - Interview with Chief Medical Officer Dr. Monica Luchi Presented by Small Cap Nation Uploaded on…
Jane King interviews CEO of Immune Pharamaceuticals Daniel Tepper about their recent breakthrough in medical technology. Uploaded on Dec 15, 2015 Smallcap Nation Source: https://upticknewswire.com/imnp-jane-king-interviews-daniel-tepper-ceo-of-immune-pharmaceuticals
Jane King discusses Immune Pharmaceuticals developing technology used to help treat cancer patients. IMNP Video News Release Small Cap Nation Uploaded on Dec 16, 2015 source: https://upticknewswire.com/imnp-using-nanotechnology-for-targeted-therapy-in-oncology-patients
![A Scientific Roadmap To Cure Cancer [BIEI]](https://upticknewswire.com/wp-content/uploads/2016/01/BIEI-Logo.png){kind=logo}